OCULAR THERAPEUTIX, INC (OCUL) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Todd Anderman

Chief Legal Officer

—

$87.36K (1) scheduled

−$87.36K

140,484

0.0640%

$1.02M

+42.3%

Pravin Dugel

See Remarks

—

3,270,332

1.49%

$23.84M

+302.5%

Donald Notman

Chief Operating Officer

—

366,529

0.1669%

$2.67M

+70.5%

Sanjay Nayak

Chief Strategy Officer

—

326,898

0.1488%

$2.38M

+85.5%

Jeffrey S. Heier

Chief Scientific Officer

—

307,457

0.1400%

$2.24M

+11.9%

Nadia Waheed

Chief Medical Officer

—

300,079

0.1366%

$2.19M

+111.8%

Richard L Md Lindstrom

Director

—

260,933

0.1188%

$1.90M

+60.4%

Namrata Saroj

Chief Business Officer

—

254,620

0.1159%

$1.86M

+26.4%

Peter Kaiser

Chief Development Officer

—

254,388

0.1158%

$1.85M

+16.4%

Steve Lawrence Meyers

Chief Commercial Officer

—

217,628

0.0991%

$1.59M

+42.5%

David Wayne Robinson

Global CCO

—

136,000

0.0619%

$991.44K

—

Charles M Warden

Director

—

100,464

0.0457%

$732.38K

+38.6%

Jason Shand Robins

Chief Financial Officer

—

68,097

0.0310%

$496.43K

+29.3%

Leslie J. Williams

Director

—

65,433

0.0298%

$477.01K

+74.8%

Adrienne L Graves

Director

—

64,000

0.0291%

$466.56K

+77.8%

Merilee Raines

Director

—

60,933

0.0277%

$444.20K

+85.0%

Seung Suh Hong

Director

—

60,933

0.0277%

$444.20K

+85.0%

OCULAR THERAPEUTIX, INC

What the insiders did Scheduled selling only

By person